Published in Anesthesiology on July 01, 2008
Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity. Physiol Behav (2010) 1.80
Hyperlipidemic diet causes loss of olfactory sensory neurons, reduces olfactory discrimination, and disrupts odor-reversal learning. J Neurosci (2014) 1.58
Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease. Cardiovasc Diabetol (2012) 1.21
Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes. J Neuropathol Exp Neurol (2009) 1.06
Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice. J Biol Chem (2011) 0.97
Polymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetes. PLoS One (2009) 0.97
Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcumin. Int J Endocrinol Metab (2014) 0.95
Hyperglycemia, a neglected factor during cancer progression. Biomed Res Int (2014) 0.91
Disrupted sleep and delayed recovery from chronic peripheral neuropathy are distinct phenotypes in a rat model of metabolic syndrome. Anesthesiology (2010) 0.87
Caloric restriction in Alström syndrome prevents hyperinsulinemia. Am J Med Genet A (2009) 0.84
Associations between APOE variants and metabolic traits and the impact of psychological stress. PLoS One (2011) 0.83
Anesthesia with propofol induces insulin resistance systemically in skeletal and cardiac muscles and liver of rats. Biochem Biophys Res Commun (2012) 0.82
Pleiotropic effects of incretins. Indian J Endocrinol Metab (2012) 0.80
Role of protein farnesylation in burn-induced metabolic derangements and insulin resistance in mouse skeletal muscle. PLoS One (2015) 0.80
iNOS inhibitor, L-NIL, reverses burn-induced glycogen synthase kinase-3β activation in skeletal muscle of rats. Metabolism (2012) 0.80
Development of a murine model of early sepsis in diet-induced obesity. Biomed Res Int (2014) 0.79
ZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose. Cell Death Dis (2016) 0.78
Associations of Body Composition Measurements with Serum Lipid, Glucose and Insulin Profile: A Chinese Twin Study. PLoS One (2015) 0.78
Protective Effect of Vanillic Acid against Hyperinsulinemia, Hyperglycemia and Hyperlipidemia via Alleviating Hepatic Insulin Resistance and Inflammation in High-Fat Diet (HFD)-Fed Rats. Nutrients (2015) 0.77
Efficacy and tolerability of an herbal formulation for weight management. J Med Food (2013) 0.77
iNOS as a Driver of Inflammation and Apoptosis in Mouse Skeletal Muscle after Burn Injury: Possible Involvement of Sirt1 S-Nitrosylation-Mediated Acetylation of p65 NF-κB and p53. PLoS One (2017) 0.75
Blocking iNOS and endoplasmic reticulum stress synergistically improves insulin resistance in mice. Mol Metab (2016) 0.75
Hyperglycemia triggers HIPK2 protein degradation. Oncotarget (2016) 0.75
The 482Ser of PPARGC1A and 12Pro of PPARG2 Alleles Are Associated with Reduction of Metabolic Risk Factors Even Obesity in a Mexican-Mestizo Population. Biomed Res Int (2015) 0.75
Free fatty acid oxidation in insulin resistance and obesity. Heart Metab (2010) 0.75
Effect of Slow Wave Sleep Disruption on Metabolic Parameters in Adolescents. Sleep (2016) 0.75
Role of nitric oxide (NO) metabolism and inflammatory mediators in childhood obesity. Inflamm Res (2011) 0.75
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82
Intensive insulin therapy in critically ill patients. N Engl J Med (2001) 40.00
Inflammation and metabolic disorders. Nature (2006) 33.33
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med (2007) 33.21
Global and societal implications of the diabetes epidemic. Nature (2001) 25.18
Nonalcoholic fatty liver disease. N Engl J Med (2002) 22.41
Intensive insulin therapy in the medical ICU. N Engl J Med (2006) 22.37
Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 20.19
Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med (2008) 19.93
Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science (2004) 19.08
Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med (2007) 18.45
Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27
A central role for JNK in obesity and insulin resistance. Nature (2002) 17.27
Inflammation, stress, and diabetes. J Clin Invest (2005) 17.11
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A (2003) 17.10
Cellular survival: a play in three Akts. Genes Dev (1999) 17.05
Insulin signalling and the regulation of glucose and lipid metabolism. Nature (2001) 16.41
Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature (2006) 15.48
Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science (2006) 13.91
Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA (2008) 13.69
Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature (2006) 12.13
Central nervous system control of food intake and body weight. Nature (2006) 11.89
Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res (2005) 11.88
Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med (2007) 11.62
Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature (2007) 11.59
Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol Cell (2001) 11.21
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol (2001) 10.85
Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol (2006) 10.67
Obesity and diabetes in the developing world--a growing challenge. N Engl J Med (2007) 10.54
Lifetime risk for diabetes mellitus in the United States. JAMA (2003) 10.33
Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature (2006) 10.07
Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature (2003) 9.77
Adipocytes as regulators of energy balance and glucose homeostasis. Nature (2006) 9.52
Thiazolidinediones. N Engl J Med (2004) 9.42
Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science (1997) 8.81
Obesity, inflammation, and insulin resistance. Gastroenterology (2007) 7.54
The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem (2000) 7.41
PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab (2007) 7.19
Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest (1999) 6.73
Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest (2002) 6.48
Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med (2004) 6.12
Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med (2007) 6.09
Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA (2008) 6.00
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov (2007) 5.65
Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes (1997) 5.61
Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. N Engl J Med (1999) 5.05
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest (2002) 4.96
IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab (2002) 4.93
Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem (1994) 4.90
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes (2002) 4.58
Hypothalamic K(ATP) channels control hepatic glucose production. Nature (2005) 4.56
S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature (2006) 4.54
Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature (2007) 4.20
Bariatric surgery for morbid obesity. N Engl J Med (2007) 4.16
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol (2006) 4.05
Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J Biol Chem (2004) 3.94
PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest (2004) 3.86
ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol (1999) 3.63
Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature (2007) 3.57
Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol (1992) 3.26
Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest (2001) 3.24
Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med (2001) 3.14
Strategies for safer liver surgery and partial liver transplantation. N Engl J Med (2007) 3.14
SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J Biol Chem (2001) 3.09
New drug targets for type 2 diabetes and the metabolic syndrome. Nature (2001) 2.92
Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol (2006) 2.80
JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology (2006) 2.70
Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine (2006) 2.61
Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature (2007) 2.56
White adipose tissue lacks significant vagal innervation and immunohistochemical evidence of parasympathetic innervation. Am J Physiol Regul Integr Comp Physiol (2006) 2.55
Trafficking of G protein-coupled receptors. Circ Res (2006) 2.54
Gut hormones and the regulation of energy homeostasis. Nature (2006) 2.53
Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism (1996) 2.11
Tracing from fat tissue, liver, and pancreas: a neuroanatomical framework for the role of the brain in type 2 diabetes. Endocrinology (2005) 2.10
SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat Cell Biol (2004) 2.09
Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med (2005) 1.99
S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem (2005) 1.96
Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand (2005) 1.94
Signals from intra-abdominal fat modulate insulin and leptin sensitivity through different mechanisms: neuronal involvement in food-intake regulation. Cell Metab (2006) 1.93
Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab (2003) 1.93
Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes (1996) 1.91
Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process. Diabetes (2005) 1.85
C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia (2004) 1.85
Obesity and mortality in critically ill adults: a systematic review and meta-analysis. Obesity (Silver Spring) (2008) 1.80
Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance. J Clin Invest (2004) 1.79
SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm Res (2007) 1.75
ORP150 protects against hypoxia/ischemia-induced neuronal death. Nat Med (2001) 1.74
Childhood obesity and a diabetes epidemic. N Engl J Med (2002) 1.72
Insulin reduces the multiple organ injury and dysfunction caused by coadministration of lipopolysaccharide and peptidoglycan independently of blood glucose: role of glycogen synthase kinase-3beta inhibition. Crit Care Med (2006) 1.66
Clinical experience with tight glucose control by intensive insulin therapy. Crit Care Med (2007) 1.41
Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinology (2004) 1.39
A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes (2005) 1.37
Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients. J Endocrinol (2004) 1.31
Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J Biol Chem (2005) 1.30
Analysis of thermal injury-induced insulin resistance in rodents. Implication of postreceptor mechanisms. J Biol Chem (1997) 1.29
Purification and characterization of a novel stress protein, the 150-kDa oxygen-regulated protein (ORP150), from cultured rat astrocytes and its expression in ischemic mouse brain. J Biol Chem (1996) 1.26
Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation. Shock (2007) 1.23
The role of CNS fuel sensing in energy and glucose regulation. Gastroenterology (2007) 1.19
Hypoglycemia in hospitalized adult patients without diabetes. Endocr Pract (2005) 1.19
Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle. Am J Physiol Endocrinol Metab (2004) 1.18
Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol (2007) 2.22
Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock. Circ Res (2006) 2.02
S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem (2005) 1.96
Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy. PLoS One (2007) 1.60
A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes (2005) 1.37
Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J Biol Chem (2005) 1.30
Comparison of comet assay, electron microscopy, and flow cytometry for detection of apoptosis. J Histochem Cytochem (2003) 1.29
A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload. Am J Physiol Heart Circ Physiol (2008) 1.18
Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle. Am J Physiol Endocrinol Metab (2004) 1.18
Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease. Antioxid Redox Signal (2011) 1.15
Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab (2002) 1.12
Proton NMR spectroscopy shows lipids accumulate in skeletal muscle in response to burn trauma-induced apoptosis. FASEB J (2005) 1.07
Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial. Crit Care Med (2015) 0.99
Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice. J Biol Chem (2011) 0.97
Farnesyltransferase inhibitor improved survival following endotoxin challenge in mice. Biochem Biophys Res Commun (2009) 0.96
Farnesyltransferase inhibitor, manumycin a, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2007) 0.96
Novel mitochondria-targeted antioxidant peptide ameliorates burn-induced apoptosis and endoplasmic reticulum stress in the skeletal muscle of mice. Shock (2011) 0.94
Upregulation of circulating IL-15 by treadmill running in healthy individuals: is IL-15 an endocrine mediator of the beneficial effects of endurance exercise? Endocr J (2011) 0.93
Lack of caspase-3 attenuates immobilization-induced muscle atrophy and loss of tension generation along with mitigation of apoptosis and inflammation. Muscle Nerve (2013) 0.92
Lipopolysaccharide upregulates α7 acetylcholine receptors: stimulation with GTS-21 mitigates growth arrest of macrophages and improves survival in burned mice. Shock (2012) 0.89
Simvastatin treatment improves survival in a murine model of burn sepsis: Role of interleukin 6. Burns (2010) 0.88
Farnesyltransferase inhibitor FTI-277 reduces mortality of septic mice along with improved bacterial clearance. J Pharmacol Exp Ther (2011) 0.87
Long-term effects of botulinum toxin on neuromuscular function. Anesthesiology (2007) 0.87
Adipocyte apoptosis after burn injury is associated with altered fat metabolism. J Burn Care Res (2006) 0.85
Delayed paraplegia after spinal cord ischemic injury requires caspase-3 activation in mice. Stroke (2011) 0.85
Effect of simvastatin on burn-induced alterations in tissue specific glucose metabolism: implications for burn associated insulin resistance. Int J Mol Med (2010) 0.85
Gene disruption of caspase-3 prevents MPTP-induced Parkinson's disease in mice. Biochem Biophys Res Commun (2010) 0.84
Title efficacy of phosphodiesterase 5 inhibitor on distant burn-induced muscle autophagy, microcirculation, and survival rate. Am J Physiol Endocrinol Metab (2013) 0.84
Increased insulin receptor substrate 1 serine phosphorylation and stress-activated protein kinase/c-Jun N-terminal kinase activation associated with vascular insulin resistance in spontaneously hypertensive rats. Hypertension (2004) 0.83
Nitric oxide inhibits the proliferation and invasion of pancreatic cancer cells through degradation of insulin receptor substrate-1 protein. Mol Cancer Res (2010) 0.83
Inducible nitric oxide synthase deficiency ameliorates skeletal muscle insulin resistance but does not alter unexpected lower blood glucose levels after burn injury in C57BL/6 mice. Metabolism (2011) 0.83
Anesthesia with propofol induces insulin resistance systemically in skeletal and cardiac muscles and liver of rats. Biochem Biophys Res Commun (2012) 0.82
Critical illness is associated with decreased plasma levels of coenzyme Q10: a cross-sectional study. J Crit Care (2013) 0.81
NO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic β-cells. FEBS Lett (2011) 0.81
Combined off-resonance imaging and T2 relaxation in the rotating frame for positive contrast MR imaging of infection in a murine burn model. J Magn Reson Imaging (2010) 0.80
iNOS inhibitor, L-NIL, reverses burn-induced glycogen synthase kinase-3β activation in skeletal muscle of rats. Metabolism (2012) 0.80
Anesthesia with Disuse Leads to Autophagy Up-regulation in the Skeletal Muscle. Anesthesiology (2015) 0.80
Train-of-four and tetanic fade are not always a prejunctional phenomenon as evaluated by toxins having highly specific pre- and postjunctional actions. Anesth Analg (2013) 0.79
Is normalized mean blood glucose level good enough for the intensive care unit?--glycemic variability as a new independent predictor of mortality. Crit Care Med (2008) 0.79
Reduction of cardiomyocyte S-nitrosylation by S-nitrosoglutathione reductase protects against sepsis-induced myocardial depression. Am J Physiol Heart Circ Physiol (2013) 0.79
Nonsurgically induced disuse muscle atrophy and neuromuscular dysfunction upregulates alpha7 acetylcholine receptors. Can J Physiol Pharmacol (2013) 0.79
Simvastatin protects hepatocytes from apoptosis by suppressing the TNF-α/caspase-3 signaling pathway in mice with burn injury. Ann Surg (2013) 0.79
Protective effects of a nicotinamide derivative, isonicotinamide, against streptozotocin-induced β-cell damage and diabetes in mice. Biochem Biophys Res Commun (2013) 0.78
Simvastatin reduces burn injury-induced splenic apoptosis via downregulation of the TNF-α/NF-κB pathway. Ann Surg (2015) 0.78
Could insulin sensitization be used as an alternative to intensive insulin therapy to improve the survival of intensive care unit patients with stress-induced hyperglycemia? Crit Care Med (2009) 0.77
In vivo micro-circulation measurement in skeletal muscle by intra-vital microscopy. J Vis Exp (2007) 0.77
Prevention of Burn-Induced Inflammatory Responses and Muscle Wasting By GTS-21, A Specific Agonist for α7 Nicotinic Acetylcholine Receptors. Shock (2016) 0.76
Immobilization with atrophy induces de novo expression of neuronal nicotinic α7 acetylcholine receptors in muscle contributing to neurotransmission. Anesthesiology (2014) 0.76
Role of Elevated Fibrinogen in Burn-Induced Mitochondrial Dysfunction: Protective Effects of Glycyrrhizin. Shock (2016) 0.75
Up-regulation of acetylcholine receptors during subchronic infusion of pancuronium is caused by a posttranscriptional mechanism related to disuse. Crit Care Med (2004) 0.75
Steroidal nondepolarizing muscle relaxants do not simulate the effects of glucocorticoids on glucocorticoid receptor-mediated transcription in cultured skeletal muscle cells. Anesthesiology (2004) 0.75
Prolonged administration of pyridostigmine impairs neuromuscular function with and without down-regulation of acetylcholine receptors. Anesthesiology (2013) 0.75